Haemophilus Influenzae Type B Vaccine - Hiberix

Medical Supplies & Equipment Home

Other

All items

Haemophilus Influenzae Type B Vaccine - Hiberix

GSK

SKUGSK00018

$
38.32

excl. GST each

Quantity

Enter the quantity you'd like to find a price that's right for you.

Price each

Total:

$38.32

Please note: Item is out of stock. Estimated dispatch 2 days from date of order.

Calculate shipping

Haemophilus Influenzae Type B Vaccine - Hiberix

The Hiberix vaccine is a non-infectious immunization product designed to prevent invasive diseases caused by Haemophilus influenzae type b (Hib). This vaccine is suitable for children aged 6 weeks to 4 years and is administered intramuscularly. It is supplied in two presentations a vial with a lyophilized antigen component and a vial or prefilled syringe of sterile saline diluent. The vaccine works by stimulating the body to produce antibodies against Hib, offering protection against serious illnesses such as brain inflammation and throat infections.

Key Features

Active Ingredient Haemophilus influenzae type b bacteria bound to tetanus toxoid
Indicated for children aged 6 weeks to 4 years
Administered intramuscularly
Supplied in vial and prefilled syringe presentations

Application

Used for the prevention of Hib infections in young children, particularly those under 18 months of age.

About the Brand

Hiberix is a product of GlaxoSmithKline, a leading pharmaceutical company known for its innovative vaccines and commitment to public health.